Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cediranib with Cisplatin and Pemetrexed in Malignant Pleural Mesothelioma
NCT01064648Phase 2Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- Mar 2010
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cediranib in malignant pleural mesothelioma (MPM), sponsored by National Cancer Institute. Started Mar 2010; status: active, not recruiting.
02
Drugs
cediranib
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT01064648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01064648.